Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
Quote Panel
Key Metrics
Fundamentals
Relative Strength
603456.SS
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Forecast
Analyst rating
Last analyst upgrade/downgrade
Earnings Growth
YoY
Current
Estimates
Q2.23
+22%
0.38
vs 0.31
Q3.23
+16%
0.38
vs 0.33
Q4.23
-65%
0.07
vs 0.21
Q1.24
+25%
0.26
vs 0.21
Q2.24
-30%
0.27
vs 0.38
Q3.24
-55%
0.17
vs 0.38
Q4.24
N/A
-0.03
vs 0.07
Q1.25
+6%
0.28
vs 0.26
Q2.25
-17%
0.22
vs 0.27
Q3.25
+79%
0.31
vs 0.17
Sales Growth
YoY
Current
Estimates
Q2.23
-5%
1.5B vs 1.6B
Q3.23
-7%
1.3B vs 1.4B
Q4.23
-13%
930M vs 1.1B
Q1.24
-17%
1.5B vs 1.8B
Q2.24
-15%
1.3B vs 1.5B
Q3.24
-9%
1.2B vs 1.3B
Q4.24
+29%
1.2B vs 930M
Q1.25
+2%
1.5B vs 1.5B
Q2.25
+17%
1.5B vs 1.3B
Q3.25
+25%
1.5B vs 1.2B
Return on Equity
QoQ
Q2.23
+4%
0.04
vs 0.03
Q3.23
+4%
0.04
vs 0.04
Q4.23
+1%
0.01
vs 0.04
Q1.24
+3%
0.03
vs 0.01
Q2.24
+3%
0.03
vs 0.03
Q3.24
+2%
0.02
vs 0.03
Q4.24
0%
-0.00
vs 0.02
Q1.25
+3%
0.03
vs -0.00
Institutionnal Ownership
Forecast
312%2026-Revenue
286%2026-EPS
421%2026-EBITDA
Analyst rating
Strong Sell
Sell
Buy
Neutral
Strong Buy
Price Target
NaN(-100.00%)
Number of analyst
Last analyst upgrade/downgrade
No Data Available
Zhejiang Jiuzhou Pharmaceutical Co., Ltd manufactures and sells active pharmaceutical ingredients (API) and intermediates in China and internationally. Its API pipeline comprise central nervous system, non-steroidal, anti-infection, hypoglycemic and antiviral, tumor treatment, anti-depressant, Parkinson, HCV drugs, diabetes, cardiovascular, and respiratory anti-infection drugs. The company also provides asymmetric catalysts and lithium battery materials. Zhejiang Jiuzhou Pharmaceutical Co., Ltd was founded in 1973 and is headquartered in Taizhou, China.
SHH
EPS improving
EPS improving
0.92Â ( 5.92%)
Relative Strenght
Volume Buzz
141%
Earning Acce
No
Dist 52w H.
11%Quote Panel
Key Metrics
Relative Strength
603456.SS
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Fundamentals
P/E Ratio
P/S Ratio
P/B Ratio
Debt/Equity
Net Margin
EPS
How 603456.SS compares to sector?